Yes, ATP can be a biomarker, specifically in certain contexts.
Based on the reference provided, circulating levels of ATP correlate with cognitive decline in HIV-infected individuals, suggesting that ATP is a biomarker of cognitive disease in the HIV-infected population.
ATP as a Biomarker: Key Points
-
Specific Context: The reference highlights ATP's role as a biomarker in the context of cognitive decline in HIV-infected individuals. This implies that its biomarker status might be specific to certain diseases or conditions.
-
Cognitive Decline: Elevated or altered levels of ATP in circulation may indicate the presence or progression of cognitive impairment in the specified population.
Example
- Measuring ATP levels in blood samples from HIV-infected patients might help in assessing their risk for or the severity of cognitive decline.
